---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-088678"
form_type: "8-K"
ticker: "OCGN"
cik: "0001372299"
company_name: "Ocugen, Inc."
filed_at: "2024-08-13T23:59:59+00:00"
generated_at: "2026-05-31T09:38:37.065428+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Ocugen posts corporate presentation on website; no new material financial or operational details

## Summary
- Presentation covers gene and cell therapies and vaccines pipeline; no specific data disclosed.
- No financial results, guidance, or business updates provided in the filing.
- Presentation slide shows only a cover page with general mission statement.

## SEC filing metadata
- accession: 0001104659-24-088678
- form_type: 8-K
- ticker: OCGN
- cik: 0001372299
- company_name: Ocugen, Inc.
- filed_at: 2024-08-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372299/000110465924088678/0001104659-24-088678-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372299/000110465924088678/tm2421524d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-088678
- JSON: https://secwatch.observer/filing/0001104659-24-088678.json
- Plain text: https://secwatch.observer/filing/0001104659-24-088678.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.